IBDRY Stock UPDATES Iberdrola ADR (IBDRY) 28.6800 09/16/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Iberdrola ADR (IBDRY) 28.6800 $IBDRY

Don't Sell Cheniere Energy at Its All-Time High, Just Wait for It
at The Street - Tue Jul 01, 2:53PM CDT
Cheniere Energy has signed two new Corpus Christi related deals as shares hit all-time high levels. There are other catalysts at work that can push this stock even higher.

Iberdrola Chairman: We are an engine for economic growth
PR Newswire - Fri Mar 28, 6:21AM CDT
Today, Iberdrola (IBDRY:US) chairman Ignacio Galan addressed attendees at the Group's Annual General Meeting (AGM) and reiterated the important role the Company plays as an engine for economic growth in countries where it operates. Galan highlighted the projected rate of capital investment, estimated at EUR 9.6 billion ($12.5 billion USD) between 2014-2016, as well as the secondary benefits of corporate purchasing, tax payments, and job creation. As examples he cited EUR 4.4 billion ($5.8 billion USD) in corporate purchases and EUR 5.4 billion ($7.2 billion USD) in tax payments worldwide in 2013.

Why a Valentine's Conception Needs More Than a Card and Roses
PR Newswire - Fri Feb 14, 6:37AM CST
Pressure to make Valentine's Day all about sex and passion can feel daunting for 1 in 10 women in the US who face difficulty conceiving. Moreover, over the last three decades, women have been waiting longer to start having children. However, when it comes to fertility, age matters; both women and men are at their most fertile in their early twenties.

Iberdrola Chairman to shareholders: Spain is beginning to recover from economic crisis
PR Newswire - Fri Mar 22, 6:30AM CDT
Iberdrola (IBDRY:US) chairman Ignacio Galan told shareholders today that despite a difficult economic environment, Iberdrola again generated solid results in 2012, driven by 35% net earnings growth in its international operations. The Company was one of the few European utilities to have maintained profit and dividends to shareholders since the economic crisis began in 2008.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Securitize's Bold Move: Venturing into Asset-backed Lending

Updated Category News Views 48

Jumping into the Big League Securitize Corp. is shaking things up with its latest strategic move to acquire River One, an asset-backed financing firm. Now, this ain't just another run-of-the-mill acquisition to throw in the pile—it positions Securitize to plunge into the massive $6 trillion private asset-backed finance market. That's the kind of hefty expansion that...

Continue Reading
NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 11

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 70

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
Ex-Special Ops Leader Fenton Joins SAGINT's Advisory Board

Updated Category News Views 22

If you’ve been around long enough, you know that in defense, the game’s all about who you know and how you move. And in this arena, General Bryan P. Fenton doesn’t just walk in—he bursts through the darn doors with gravitas honed by years commanding folks who live by grit and sinew. His latest move? Clambering aboard the SAGINT® Board of Advisors, ready to tackle...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 279

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 75

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading
Illinois Ban Risks Boosting Illicit THC Drink Sales

Updated Category News Views 61

Illinois Cranks Up the Heat on Low-Dose THC Drinks Illinois, you've really done it this time. When it comes to low-dose THC beverages, the state is setting up shop for illicit sellers by going harsher than federal standards. On November 12, these drinks, which have a loyal following, will be off the shelves—thanks to a reclassification that lumps them in with more...

Continue Reading
Celebrating Science with Southeastern Tile's Sponsorship

Updated Category News Views 65

Crafting Pathways and Fostering Curiosity In this world of rapid change and relentless innovation, supporting education—especially in science and technology—is like buying a piece of the future. And, boy, is Southeastern Tile Connection onto something with that. They've stepped up as an Exploration Sponsor for the Asheville Museum of Science's (AMOS) annual gala,...

Continue Reading
Ionis Faces Legal Scrutiny Amid Slashed Sales Forecast

Updated Category News Views 57

Ionis Pharmaceuticals Takes a Hit: What's Happening? November 9, 2026, wasn't just another dreary market day—especially if you've got a stake in Ionis Pharmaceuticals. Today, they whittled down their full-year sales forecast for TRYNGOLZA from a cozy $100 million to $110 million range to a startling $50 million. NASDAQ: IONS shares naturally took a nosedive, and as...

Continue Reading
Blurry Vision Explained: Beyond Just a Lens Issue

Updated Category News Views 69

Why Your Vision Might Be Blurry: It's Not Always Simple Dr. Spencer Franz isn’t just another face behind an optometry chart. He’s tackling a topic as blurry as it is relatable—your vision. You'd think a simple tweak of your glasses script might do the trick, but surprise, surprise, vision issues are sneakier than that. Changes in prescriptions are a dime a dozen,...

Continue Reading

Top 5 Most Recently Viewed Articles

Euroseas Ltd. Gains Momentum with New Charter for M/V Jonathan P

Updated Category News Views 35

New Charter Contract for M/V Jonathan P Euroseas Ltd. (NASDAQ: ESEA), an esteemed player in the container shipping industry, proudly announces the establishment of a time charter contract for its 1,732 TEU feeder containership, M/V Jonathan P. This contract spans a minimum of 11 months and may extend to a maximum of 13 months at a favorable gross daily rate of $20,000....

Continue Reading
An In-depth Comparison of Micron Technology in the Chip Sector

Updated Category News Views 568

Understanding Micron Technology's Position in the Semiconductor Industry In the dynamic world of semiconductors, evaluating a company effectively is vital for investors looking to make educated decisions. This article provides a thorough comparison of Micron Technology (NASDAQ: MU) against its competitors, shedding light on essential financial metrics and growth...

Continue Reading
Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Updated Category News Views 70

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Continue Reading
Marvell Technology Reports Impressive Q3 Earnings Growth

Updated Category News Views 269

Marvell Technology Posts Strong Q3 Earnings Marvell Technology Inc. (NASDAQ: MRVL) delivered an impressive financial performance for the third quarter, significantly surpassing market expectations. The company reported quarterly adjusted earnings of 76 cents per share, outperforming the analyst estimate of 73 cents, according to recent analytical reports. With quarterly...

Continue Reading
OkayCoin Launches Free Trial Staking for New Crypto Investors

Updated Category News Views 54

Introducing OkayCoin's Revolutionary Free Trial Liquid Staking OkayCoin has made an exciting move in the cryptocurrency sector by introducing a new Free Trial Liquid Staking program aimed at welcoming new investors. This innovative solution allows newcomers to experience the world of crypto staking with a minimal investment of just $100, providing an accessible entry...

Continue Reading